Skip to main content

Fiscal Wizard · Single-issue tearsheet

MMSI / Jun 21, 2026 Run #7509

MMSI

Merit Medical Systems, Inc.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Composite verdict

F 22.8 / 100
Bearish setup · Mean Reversion 5 drivers · 2 gates blocking
  • Wedge Pattern
  • Bollinger Reentry
  • Stochastic Cross
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 29th of 57 in Medical Instruments & Supplies

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 18 signals100% Bear
Momentum Neutral 45Mean-reversion Bearish 15

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -55%
Asset value $26.56Earnings power value $21.04Price $67.22

Priced above its no-growth earnings power value ($21.04/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Mixed

42.7 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
FCF Margin 76
PEG 0
Greenblatt EY 75
Margin of Safety 0
Return on Assets 75
OCF to Net Income 0

Technicals Bearish

2.9 / 100

Bearish setup leads (Wedge Pattern, Bollinger Reentry, Stochastic Cross); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Wedge Pattern 9
Bollinger Reentry 19
Stochastic Cross 21

Risk Gates

2 blocking 6 caution

2 guards active, 23 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for MMSI.